(5044) Mcot
Payments companies reported to CMS as associated with (5044) Mcot. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (5044) Mcot, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (5044) Mcot
These are the largest totals companies reported as associated with (5044) Mcot. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Alexander Chernobelsky | Wellington, FL | Cardiovascular Disease | $35,220.00 |
| Nida Yousef | Oak Lawn, IL | Pediatric Cardiology | $30,000.00 |
| Keith Newby | Norfolk, VA | Cardiovascular Disease | $30,000.00 |
| Ralph Verdino | Philadelphia, PA | Clinical Cardiac Electrophysiology | $30,000.00 |
| Nelson Hager | Tacoma, WA | Physical Medicine & Rehabilitation | $3,105.00 |
| Mohamed Elshazly | Lake Mary, FL | Clinical Cardiac Electrophysiology | $521.65 |
| Jonathan Salcedo | Redwood City, CA | Clinical Cardiac Electrophysiology | $474.29 |
| Ashish Gupta | Phoenix, AZ | Cardiovascular Disease | $470.73 |
| Saugato Sanyal | Marlton, NJ | Cardiovascular Disease | $394.09 |
| Paulo Guillinta | Chula Vista, CA | Cardiovascular Disease | $385.01 |
Prescribed (5044) Mcot?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.